REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Prince Pharmaceutical Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Prince Pharmaceutical Co., Ltd. Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Prince Pharmaceutical Co., Ltd. is engaged in APIs and biochemical functional foods. The company's main products include active pharmaceutical ingredient, biochemical functional foods, and various dosage forms of health foods. The company was established in 1962 and is headquartered in Yunlin County, Taiwan.

Headquarters
No. 168 Keyun S. Rd., Huwei Township, Yunlin County
Tainan City; Tainan City;

Contact Details: Purchase the Prince Pharmaceutical Co., Ltd. report to view the information.

Website: http://www.prince-pharm.com.tw

Basic Information
Total Employees:
Purchase the Prince Pharmaceutical Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Prince Pharmaceutical Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Prince Pharmaceutical Co., Ltd. report to view the information.
Incorporation Date:
July 31, 1962
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Assistant Vice President
Ownership Details
Purchase this report to view the information.
50.1%
Purchase this report to view the information.
2.9%
Purchase this report to view the information.
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Prince Pharmaceutical Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
-5.46%▼
Total operating revenue
-5.46%▼
Operating profit (EBIT)
-76.2%▼
EBITDA
-42.64%▼
Net Profit (Loss) for the Period
-82.9%▼
Total assets
3.13%▲
Total equity
18.16%▲
Operating Profit Margin (ROS)
-8.7%▼
Net Profit Margin
-7.27%▼
Return on Equity (ROE)
-4.49%▼
Debt to Equity Ratio
-17.92%▼
Quick Ratio
0.4%▲
Cash Ratio
0.23%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo